Helix BioPharma Corp. (HBP.TO)
CAD 1.0
(5.26%)
CAD 1.0
(5.26%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -5.21 Million | -5.52 Million | -6.5 Million | -9.3 Million | -10.82 Million | -5.53 Million |
| Net Income | -9.26 Million | -6.29 Million | -6.56 Million | -8.03 Million | -8.56 Million | -7.52 Million |
| Depreciation & Amortization | 14 Thousand | 13 Thousand | 12 Thousand | 199 Thousand | 211 Thousand | 125 Thousand |
| Deferred income taxes | - | - | 9000.00 | -2.21 Million | - | - |
| Stock-based compensation | - | 570 Thousand | 425 Thousand | 664 Thousand | 471 Thousand | 361 Thousand |
| Change in working capital | 485 Thousand | 186 Thousand | -892 Thousand | -54 Thousand | -2.11 Million | 1.47 Million |
| Other non-cash items | 3.54 Million | -5000.00 | 500 Thousand | 142 Thousand | -836 Thousand | 36 Thousand |
| Investing Cash Flow | -14 Thousand | -5000.00 | - | 2.02 Million | 1.7 Million | -4000.00 |
| Investments in PPE | -14 Thousand | -10 Thousand | - | - | -16 Thousand | -4000.00 |
| Acquisitions | - | 5000.00 | - | 2.02 Million | 1.72 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 5000.00 | - | 2020.00 | 1720.00 | -2000.00 |
| Financing Cash Flow | 5.5 Million | 3.08 Million | 6.2 Million | 6.56 Million | 13.09 Million | 5.41 Million |
| Debt repayment | - | -2.06 Million | - | -158 Thousand | -151 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 5.5 Million | 4.15 Million | 6.2 Million | 3.56 Million | 12.18 Million | 5.41 Million |
| Other Financing Activities | - | 999 Thousand | 6.2 Million | 3.15 Million | 1.06 Million | 5411.00 |
| Accounts receivables | -186 Thousand | 217 Thousand | 74 Thousand | -173 Thousand | 61 Thousand | 25 Thousand |
| Accounts payables | - | -106 Thousand | -867 Thousand | 50 Thousand | -1.54 Million | 1.04 Million |
| Inventory | - | - | - | - | - | 314 Thousand |
| Other working capital | 671 Thousand | 75 Thousand | -99 Thousand | 69 Thousand | -627 Thousand | 86 Thousand |
| Cash at beginning of period | 808 Thousand | 3.25 Million | 3.56 Million | 4.23 Million | 206 Thousand | 366 Thousand |
| Cash at end of period | 1.08 Million | 808 Thousand | 3.25 Million | 3.56 Million | 4.23 Million | 206 Thousand |
| Capital Expenditure | -14 Thousand | -10 Thousand | - | - | -16 Thousand | -4000.00 |
| Effect of forex changes on cash | - | - | -9000.00 | 52 Thousand | 55 Thousand | -36 Thousand |
| Net cash flow / Change in cash | 273 Thousand | -2.44 Million | -313 Thousand | -670 Thousand | 4.02 Million | -160 Thousand |
| Free Cash Flow | -5.23 Million | -5.53 Million | -6.5 Million | -9.3 Million | -10.84 Million | -5.53 Million |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.27 Million | -1.83 Million | -902 Thousand | -1.25 Million | -2.15 Million | -6.29 Million |
| Depreciation & Amortization | 3000.00 | 3000.00 | 3000.00 | 4000.00 | 4000.00 | 13 Thousand |
| Deferred income taxes | - | - | - | 12 Thousand | - | - |
| Stock-based compensation | - | 6000.00 | 21 Thousand | 34 Thousand | 397 Thousand | 570 Thousand |
| Change in working capital | 1.06 Million | 686 Thousand | -645 Thousand | -624 Thousand | 233 Thousand | 186 Thousand |
| Other non-cash items | 3.45 Million | 48 Thousand | 50 Thousand | -24 Thousand | -19 Thousand | -5000.00 |
| Investing Cash Flow | -2000.00 | - | - | -12 Thousand | 4000.00 | -5000.00 |
| Investments in PPE | -2000.00 | - | - | -12 Thousand | -1000.00 | -10 Thousand |
| Acquisitions | - | - | - | - | 5000.00 | 5000.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 5.00 | 5000.00 |
| Financing Cash Flow | 1.09 Million | 1.72 Million | 1000.00 | 2.68 Million | 998 Thousand | 3.08 Million |
| Debt repayment | - | - | - | - | -406 Thousand | -2.06 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -2.68 Million | - | - | - |
| Common Stock Issuance | 1.09 Million | 1.72 Million | 1000.00 | 2.68 Million | -406 Thousand | 4.15 Million |
| Other Financing Activities | - | 1.72 Million | 2.68 Million | 2686.00 | 1.81 Million | 999 Thousand |
| Accounts receivables | -160 Thousand | -25 Thousand | 6000.00 | -7000.00 | 51 Thousand | 217 Thousand |
| Accounts payables | - | 852 Thousand | -673 Thousand | 399 Thousand | 102 Thousand | -106 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.22 Million | 133 Thousand | -651 Thousand | -1.01 Million | 80 Thousand | 75 Thousand |
| Cash at beginning of period | 710 Thousand | 120 Thousand | 1.64 Million | 808 Thousand | 1.33 Million | 3.25 Million |
| Cash at end of period | 1.08 Million | 710 Thousand | 120 Thousand | 1.64 Million | 808 Thousand | 808 Thousand |
| Capital Expenditure | -2000.00 | - | - | -12 Thousand | -1000.00 | -10 Thousand |
| Effect of forex changes on cash | - | -8000.00 | -5000.00 | -12 Thousand | 15 Thousand | - |
| Net cash flow / Change in cash | 371 Thousand | 590 Thousand | -1.52 Million | 833 Thousand | -522 Thousand | -2.44 Million |
| Free Cash Flow | -750 Thousand | -1.12 Million | -1.49 Million | -1.86 Million | -1.54 Million | -5.53 Million |
AILLO
WARDINMOBI
605259
600831
DTATF
3576